Consun Pharmaceutical Group Limited (HKG:1681)

HKG:1681 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,243	2,908	2,748	2,450	2,196	1,940
Short-Term Investments	1,794	958	834.94	589.17	230	-
Cash & Short-Term Investments	4,037	3,866	3,583	3,039	2,426	1,940
Cash Growth	12.73%	7.88%	17.89%	25.26%	25.05%	40.27%
Accounts Receivable	296.34	297.57	255.84	259.56	351.23	448.54
Other Receivables	98.21	72.55	54.13	36.1	18.34	9.89
Receivables	394.55	370.12	309.97	295.66	369.57	458.43
Inventory	286.7	315.51	384.91	287.66	257.62	227.37
Restricted Cash	4.37	-	-	-	2.32	-
Other Current Assets	43.47	-	-	-	-	32.62
Total Current Assets	4,766	4,551	4,278	3,623	3,056	2,659
Property, Plant & Equipment	915.2	925.54	863.71	875	858.45	799.45
Long-Term Investments	63.31	29.08	9.23	6.5	-	-
Other Intangible Assets	267.28	268.96	283.14	311.9	341.66	371.42
Long-Term Deferred Tax Assets	14.7	12.52	17.84	36.43	46.86	58.89
Other Long-Term Assets	66.11	65.67	55.99	39.87	59.94	61.8
Total Assets	6,093	5,853	5,508	4,892	4,363	3,950
Accounts Payable	96.86	75.64	83.1	59.89	66.64	50.89
Accrued Expenses	777.19	736.12	638.76	566.13	465.53	406.42
Current Portion of Long-Term Debt	239.28	253.34	503.42	450.52	599.3	549.41
Current Portion of Leases	9.49	6.42	4.22	3.71	3.12	-
Current Income Taxes Payable	45.73	47.63	43.38	32.89	2.54	71.11
Current Unearned Revenue	52.76	60.82	17.56	39.98	21.21	15.49
Other Current Liabilities	126.83	190.83	204.57	197.37	199.07	238.55
Total Current Liabilities	1,348	1,371	1,495	1,350	1,357	1,332
Long-Term Leases	4.58	7.41	3.9	5.95	8.55	-
Long-Term Unearned Revenue	13.79	14.64	19.18	18.93	16.7	15.63
Long-Term Deferred Tax Liabilities	80.03	67.19	71.21	78.01	69.3	86.26
Total Liabilities	1,447	1,460	1,589	1,453	1,452	1,434
Common Stock	67.58	67.31	63.81	63.45	64.8	64.42
Additional Paid-In Capital	-	216.46	18.15	-	19.79	-
Retained Earnings	-	3,650	3,381	2,913	2,393	2,003
Treasury Stock	-	-	-83.17	-83.17	-113.32	-88.64
Comprehensive Income & Other	4,283	163.67	247.15	251.7	253.89	241.38
Total Common Equity	4,350	4,098	3,627	3,145	2,618	2,220
Minority Interest	296.32	295.45	292.21	293.87	293.08	296.13
Shareholders' Equity	4,646	4,393	3,919	3,439	2,911	2,516
Total Liabilities & Equity	6,093	5,853	5,508	4,892	4,363	3,950
Total Debt	253.35	267.17	511.53	460.18	610.97	549.41
Net Cash (Debt)	3,784	3,599	3,072	2,579	1,815	1,391
Net Cash Growth	23.43%	17.15%	19.10%	42.08%	30.52%	67.64%
Net Cash Per Share	4.43	4.32	3.84	3.26	2.26	1.70
Filing Date Shares Outstanding	850.4	830.83	792.43	788.39	805.64	799.83
Total Common Shares Outstanding	850.4	830.83	792.43	788.39	805.64	799.83
Working Capital	3,418	3,181	2,783	2,272	1,698	1,327
Book Value Per Share	5.12	4.93	4.58	3.99	3.25	2.78
Tangible Book Value	4,083	3,829	3,343	2,833	2,276	1,849
Tangible Book Value Per Share	4.80	4.61	4.22	3.59	2.83	2.31
Buildings	-	399.2	338.28	334.82	334.1	333.15
Machinery	-	363.52	324.86	302.16	282.15	269
Construction In Progress	-	412.24	416.43	416.01	381.67	314.65

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.